The research company Peptonic Medical announces that warrants of series TO6 have been exercised to about 60.2 percent. In total, around 6.9 billion new shares were subscribed for at a price of SEK 0.0011 per share. Through the exercise, the company receives about SEK 7.5 million before issue costs and set-offs, according to a press release. For shareholders who chose not to exercise any TO6, the dilution amounts to about 24.9 percent of the number of shares and votes in the company.